Author

A. R. White

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Khosla· 1 shared A. Pebay· 1 shared C. Cuni-Lopez· 1 shared D. C. Nelson· 1 shared G. L. Redlich· 1 shared H. Quek· 1 shared J. A. Mendez· 1 shared J. C. S. Chaves· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPlant Biology

A. Khosla

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Increased tau expression in the APOE4 blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery in vitro.

J. M. Wasielewska, R. Bajracharya, R. L. Johnston, J. C. S. Chaves, A. Pebay, L. E. Oikari, J. Götz, R. M. Nisbet, A. R. White

This study shows that APOE4 increases tau levels in brain endothelial cells, reducing anti-tau antibody delivery across the blood-brain barrier in vitro.

bioRxiv · Oct 24, 2023 · PreprintCell Biology

A novel patient-derived cellular platform for validating microglia-targeted therapeutics for Alzheimer's disease

C. Cuni-Lopez, R. Stewart, S. Okano, G. L. Redlich, M. W. Appleby, A. R. White, H. Quek

This study develops a patient-derived cellular platform to test microglia-targeted therapeutics for Alzheimer's disease, finding that 3D models better distinguish drug responses between healthy and patient donors.

bioRxiv · Aug 17, 2023 · PreprintCell Biology

Rapid analysis of strigolactone receptor activity in a Nicotiana benthamiana dwarf14 mutant

A. R. White, J. A. Mendez, A. Khosla, D. C. Nelson

The paper evaluates AtD14 mutants' ability to degrade AtSMXL7 in N. benthamiana D14 mutants, showing that catalytic activity is required for this function.

bioRxiv · May 11, 2021Plant Biology